IT Asset Management Firm
Search our website
Robin D. Campbell
Robin D. Campbell Associate Partner
Dr. Campbell’s professional career spans more than 25 years and includes both U.S. and international experience in pharmaceutical and biotechnology sales, marketing, product development and general management. Currently, he is President and CEO of LaunchPoint BioMEMS, a private medical device company specializing in miniaturized wireless pressure sensors. He is also a Lecturer in the Technology Management Program of the College of Engineering at the University of California at Santa Barbara. Prior to joining LaunchPoint BioMEMS in October 2008, Dr. Campbell was President and CEO of Naryx Pharma, a specialty biopharmaceutical company. From 1989-2002, Dr. Campbell was at Amgen Inc., where his last position was Vice President and General Manager of the Oncology Business Unit, and an Amgen Officer. In this role, Dr. Campbell led an integrated team responsible for the marketing, sales, and medical development of products with over $1 billion in revenue. Dr. Campbell has provided consulting services to a number of companies in the fields of biomedical product development and corporate strategy development.
|Powered by Sigsiu.NET|